Cargando…
Clinical impacts of genomic copy number gains at Xq28
Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and termin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785515/ https://www.ncbi.nlm.nih.gov/pubmed/27081496 http://dx.doi.org/10.1038/hgv.2014.1 |
_version_ | 1782420412244688896 |
---|---|
author | Yamamoto, Toshiyuki Shimojima, Keiko Shimada, Shino Yokochi, Kenji Yoshitomi, Shinsaku Yanagihara, Keiko Imai, Katsumi Okamoto, Nobuhiko |
author_facet | Yamamoto, Toshiyuki Shimojima, Keiko Shimada, Shino Yokochi, Kenji Yoshitomi, Shinsaku Yanagihara, Keiko Imai, Katsumi Okamoto, Nobuhiko |
author_sort | Yamamoto, Toshiyuki |
collection | PubMed |
description | Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and terminal duplications (functional disomy) derived from translocation with other chromosomes. The most commonly duplicated region includes methyl CpG-binding protein 2 gene (MECP2), which has a minimal duplicated size of 0.2 Mb. Patients with MECP2 duplications show severe ID, intractable seizures and recurrent infections. Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene (GDI1) and ras-associated protein RAB39B gene (RAB39B), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications. In addition, large duplications, including MECP2 and GDI1, induce hypoplasia of the corpus callosum. Abnormalities observed in the white matter, revealed by brain magnetic resonance imaging, are a common finding in patients with MECP2 duplications. As primary sequence analysis cannot be used to determine the region responsible for chromosomal duplication syndrome, finding this region relies on the collection of genotype–phenotype data from patients. |
format | Online Article Text |
id | pubmed-4785515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47855152016-04-14 Clinical impacts of genomic copy number gains at Xq28 Yamamoto, Toshiyuki Shimojima, Keiko Shimada, Shino Yokochi, Kenji Yoshitomi, Shinsaku Yanagihara, Keiko Imai, Katsumi Okamoto, Nobuhiko Hum Genome Var Review Article Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and terminal duplications (functional disomy) derived from translocation with other chromosomes. The most commonly duplicated region includes methyl CpG-binding protein 2 gene (MECP2), which has a minimal duplicated size of 0.2 Mb. Patients with MECP2 duplications show severe ID, intractable seizures and recurrent infections. Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene (GDI1) and ras-associated protein RAB39B gene (RAB39B), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications. In addition, large duplications, including MECP2 and GDI1, induce hypoplasia of the corpus callosum. Abnormalities observed in the white matter, revealed by brain magnetic resonance imaging, are a common finding in patients with MECP2 duplications. As primary sequence analysis cannot be used to determine the region responsible for chromosomal duplication syndrome, finding this region relies on the collection of genotype–phenotype data from patients. Nature Publishing Group 2014-07-24 /pmc/articles/PMC4785515/ /pubmed/27081496 http://dx.doi.org/10.1038/hgv.2014.1 Text en Copyright © 2014 The Japan Society of Human Genetics http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Review Article Yamamoto, Toshiyuki Shimojima, Keiko Shimada, Shino Yokochi, Kenji Yoshitomi, Shinsaku Yanagihara, Keiko Imai, Katsumi Okamoto, Nobuhiko Clinical impacts of genomic copy number gains at Xq28 |
title | Clinical impacts of genomic copy number gains at Xq28 |
title_full | Clinical impacts of genomic copy number gains at Xq28 |
title_fullStr | Clinical impacts of genomic copy number gains at Xq28 |
title_full_unstemmed | Clinical impacts of genomic copy number gains at Xq28 |
title_short | Clinical impacts of genomic copy number gains at Xq28 |
title_sort | clinical impacts of genomic copy number gains at xq28 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785515/ https://www.ncbi.nlm.nih.gov/pubmed/27081496 http://dx.doi.org/10.1038/hgv.2014.1 |
work_keys_str_mv | AT yamamototoshiyuki clinicalimpactsofgenomiccopynumbergainsatxq28 AT shimojimakeiko clinicalimpactsofgenomiccopynumbergainsatxq28 AT shimadashino clinicalimpactsofgenomiccopynumbergainsatxq28 AT yokochikenji clinicalimpactsofgenomiccopynumbergainsatxq28 AT yoshitomishinsaku clinicalimpactsofgenomiccopynumbergainsatxq28 AT yanagiharakeiko clinicalimpactsofgenomiccopynumbergainsatxq28 AT imaikatsumi clinicalimpactsofgenomiccopynumbergainsatxq28 AT okamotonobuhiko clinicalimpactsofgenomiccopynumbergainsatxq28 |